Translocations involving chromosome 11, band q23, are frequent recurring abnormalities in human acute lymphoblastic and acute myeloid leukemia. We used 19 biotinlabeled probes derived from genes and anonymous cosmids for hybridization to metaphase chromosomes from leukemia cells that contained four translocations involving band 1 Iq23: t(4;11)(q21;q23), t(6;11)(q27;q23), t(9;11)(p22;q23), and t(11;19)(q23;pl3). The location of the cosmid probes relative to the breakpoint in 11q23 was the same in all translocations. Of the cosmid clones containing known genes, CD3D was proximal and PBGD, THYI, SRPR, and ETSI were distal to the breakpoint on 11q23. Hybridization of genomic DNA from a yeast clone containing yeast artificial chromosomes (YACs), that carry 320 kilobases (kb) of human DNA including CD3D and CD3G genes, showed that the YACs were split in all four translocations. These results indicate that the breakpoint at 11q23 in each of these translocations occurs within the 320 kb encompassed by these YACs; whether the breakpoint within the YACs is precisely the same in the different translocations is presently unknown)
-_ ABSTRACT
Translocations involving chromosome 11, band q23, are frequent recurring abnormalities in human acute lymphoblastic and acute myeloid leukemia. We used 19 biotinlabeled probes derived from genes and anonymous cosmids for hybridization to metaphase chromosomes from leukemia cells that contained four translocations involving band 1 Iq23: t(4;11)(q21;q23), t(6;11)(q27;q23), t(9;11)(p22;q23), and t(11;19)(q23;pl3). The location of the cosmid probes relative to the breakpoint in 11q23 was the same in all translocations. Of the cosmid clones containing known genes, CD3D was proximal and PBGD, THYI, SRPR, and ETSI were distal to the breakpoint on 11q23. Hybridization of genomic DNA from a yeast clone containing yeast artificial chromosomes (YACs) , that carry 320 kilobases (kb) of human DNA including CD3D and CD3G genes, showed that the YACs were split in all four translocations. These results indicate that the breakpoint at 11q23 in each of these translocations occurs within the 320 kb encompassed by these YACs; whether the breakpoint within the YACs is precisely the same in the different translocations is presently unknown)
Cloning of the genes involved in recurring chromosome translocations in leukemia and lymphoma has provided not only significant insights into the various mechanisms for rearrangements, but also DNA probes for diagnosis and monitoring of disease (1) (2) (3) . The isolation of translocation breakpoints in human acute myeloid leukemia (AML) has proceeded extremely slowly. One reason is the lack of cell lines that contain the relevant translocations; thus. investigators are restricted to using the limited amount of material available from patient samples. Somatic cell hybrids retaining the translocation or rearrangement of interest have had some limited usefulness. Another problem is the absence of a known gene, such as the immunoglobulin or T-cell receptor genes, that is located at the breakpoint on one of the involved chromosomes. A related problem is that DNA probes for a particular chromosome region are not available in sufficient numbers to offer a high likelihood of identifying a DNA rearrangement on Southern blot analysis either by conventional electrophoresis or by pulsed-field gel electrophoresis. We and others have used radiolabeled probes for in situ hybridization to identify genes that bracket the translocation breakpoints, although, in some cases, they showed no rearrangements on Southern blot analysis.
The use of cosmids or yeast artificial chromosomes (YACs) as probes to screen much larger segments of DNA for rearrangements provides an additional strategy for the analysis of chromosomal abnormalities; We lhave-used this strategy for the analysis of one group of chromosome translocations-namely, those involving band 11q23. This chromosome band is of great interest in human acute leukemia for at least three reasons. First, there are a large number of different recurring rearrangements that involve 11q23, and thus, along with band 14q32, 11q23 is one of the bands most frequently involved in rearrangements in human tumor cells (4) . The breakpoints in the 11q23 translocation partners include Ip32, 4q21, and 19pl3 in acute lymphoblastic leukemia (ALL) and 1q21, 2p2l, 6q27, 9p22, 10pil, 17q25, and 19pl3 in AML, especially the monoblastic and myelomonocytic subtypes. Second, these translocations occur primarily in two morphologic types of leukemia that are different but have similar features. One common translocation in infants, t(4;11)(q21;q23), usually has a lymphoblastic phenotype. although the leukemia cells may express some myeloid surface markers; in some cases, variable numbers of monocytoid blast cells have been identified (5, 6) . A cell line with the 4;11 translocation (RS4;11) has rearranged immunoglobulin heavy-chain and K light-chain genes and yet can be induced to express monoblastic features on exposure to phorbol esters (7) . These data suggest that a gene at 11q23 may be involved in determining the differentiation of primitive hematopoietic stem cells into lymphoblasts or monoblasts, or that it may be a gene that is active in both cell lineages. Third, translocations involving 11q23 have a very unusual age distribution; they comprise about two-thirds of the chromosome abnormalities in leukemia cells of children under 1 year of age (8) (9) (10) .
We report here on our use of a series of cosmid probes and fluorescence in situ hybridization techniques to map the breakpoint at 11q23 in four different recurring translocations. These studies were undertaken to determine the position of the cosmid probes relative to the breakpoints at 11q23, to determine the order of the cosmids if the breakpoints were not identical, and to bracket the translocation breakpoints with cosmid probes to facilitate additional molecular studies. (6, 7) . We also examined leukemia samples from two patients with a t(9;11), from one patient with a t (11;19) , and from one patient with a t(6;11).
Metaphase Cell Preparation. Metaphase cells were prepared from bone marrow aspirates of leukemia patients as described (11) . The RS4;11 cell line was cultured for 24 hr at 5 x 106 cells per ml; Colcemid (0.05 ,ug/ml) was added for 10-25 min and the cells were processed as described (11) .
Probes. Most of the cosmid probes for the long arm of chromosome 11 were isolated from a genomic library constructed in the cosmid vector Cos-1 (12) by using DNA from a somatic cell hybrid, TG5D1-1, containing 11ql3-qter as the only human material in a mouse erythroleukemia cell background (13) . Additional cosmid clones containing known genetic loci were isolated by using cDNA or oligonucleotide probes from this library or from a human genomic cosmid library constructed in the cosmid vector pWE15. The cosmid probes we used had been localized to 11q22-25 by fluorescence in situ hybridization (14) .
The two yeast clones were isolated from the YAC library that was described previously (15) . The YAC library was screened by one of us (P.T.-M.). One yeast clone (yB22B2) was detected by using polymerase chain reaction primers (16) (sense, GACTATCAAGAAGATGGTTC; antisense, AAG-GGGATTACATACTTCTG) specific for the CD3G gene (17) , which had previously been mapped to 11q23 (18) Repetitive DNA probes derived from pericentromeric satellite sequences of chromosomes 9 (pHur98; kindly provided by R. K. Moyzis, Los Alamos National Laboratory) and 11 (Oncor) were cohybridized with cosmid or YAC clones in some experiments for unambiguous identification of the normal and derivative chromosomes.
Fluorescence in Situ Hybridization. The procedure used for fluorescence in situ hybridization is a modification of the method described by Lichter et al. (14) . Biotin-labeled probes were prepared by nick-translation using Bio-11-dUTP (Enzo Diagnostics). Slide preparations were treated with preboiled RNase [100 ,ug/ml in 2x SSC (pH 7.0); Sigma; 1x SSC = 0.15 M NaCI/0.015 M trisodium citrate] at 37°C for 1 hr, rinsed extensively in 2x SCC, and dehydrated in a graded ethanol series (70%, 85%, 95%). Chromosomal DNA was denatured by immersion of the slides in 70%o formamide/4x SSC, pH 7.0, at 70°C for 2 min, followed by dehydration in an ethanol series. Prior to hybridization, unlabeled, sonicated total human genomic DNA (final concentration, 150 ,g/ml) was added to the hybridization mixture (50% formamide/1 x SSC/10% dextran sulfate, pH 7.0) containing the labeled probe (5-10 ng of cosmid probes per ,ul, 0.1 ,Ig of total yeast DNA per ul). The hybridization mixture was heated at 75°C for 5 min and then incubated at 37°C for 5-10 min to promote partial reannealing. Ten microliters was applied to each slide, the slides were covered with coverslips (22 mm2), and the edges were sealed with rubber cement. The slides were transferred to sealed containers and incubated for 16 hr at 37°C. After hybridization, the slides were washed in 50% formamide/4x SSC (three washes, 5 min each) at 40°C, and then in 4x SSC at 40°C (three washes, 3 min each). Thereafter, the slides were incubated with 3% bovine serum albumin (BSA) in 4x SSC for 30 min at 37°C.
The biotinylated probe was detected with fluorescein isothiocyanate (FITC)-conjugated avidin DCS (Vector Laboratories). Detection reagents were prepared in 4x SSC/0.1% Triton X-100/1% BSA, and the washes were performed in 4 x SSC/0.1% Triton X-100 at 40°C (three washes, 3 min each). For detection of the fluorochrome, slides were incubated with 5 ,ug of FITC-avidin DCS per ml at 37°C for 30 min, followed by washes. In some cases, the fluorochrome signal was amplified by incubation with 5 The results of the hybridizations of the cosmid probes to the RS4;11 cell line and to leukemia cells from the two patients with a t(9;11), one patient with a t(11;19), and one patient with a t(6;11), are shown in Table 2 and in Fig. 1 A and B. The location of the probes on either the derivative 11 [der(11)] or the translocation partner was the same in the different translocations. In the single exception (patient 1), their location did not differ; however, seven probes distal to the 11q23 breakpoint were deleted. This abnormality appeared to be a deletion because the probes were not identified on another chromosome in these cells. The order of these probes has not been established, although, based on the findings in the aforementioned patient, probes 9.4, ZA7, XH5, XB1, ZC9, PBGD, and THY) may be more proximal than the remainder of the probes that were translocated to the other chromosome involved in the rearrangement, assuming that the deletion is adjacent to the breakpoint. Similar results have been obtained using many of these same probes with another t(4;11) cell line (19) (J. Lu and D.C.W., unpublished observations). At present, we do not know the distance between the most distal of the probes that are proximal to the breakpoint at 11q23 and the most proximal of the distal probes. YAC clones were requested for all known genes in 11q23. The yeast clone containing the CD3G YACs was the first one used for in situ hybridization and it contains the CD38 and y genes and lacks CD3e. A single labeled locus on the chromosome 11 homologs was observed when DNA from the yeast clone was hybridized to normal human metaphase chromosomes. However, hybridization of these YACs to the RS4;11 cell line showed intense labeling on the normal chromosome 11 and a less intense signal on both of the rearranged der(11) and der(4) chromosomes, indicating that the breakpoint was within the 320 kb encompassed by the YACs (Fig. 1E ). These YAC probes were then hybridized to leukemia cells with a t(9;11), t(6;11), or t (11;19) (Fig. 1 C, D,  and F) . The YACs were split in each instance; that is, there Table 2 . Chromosomal localization of probes on 11q Abnormality Probe t(4;11) t(9;11)* t(9;11)t t(11;19) t (6;11) 3.16 der(11) 23.20
der (11) der (11) 1.16
der (11) der (11) der (11) der (11) der (11) 4.13
der (11) der (11) der (11) der (11) der (11) ZB6 der (11) der (11) der (11) der (11) der (11) CD3D der (11) der (11) der (11) der (11) der (11) 9.4 der(4) Deleted der (9) der (19) der (6) ZA7 der(4) Deleted der (9) der (19) der (6) XH5 der (4) Deleted der (9) der (19) der (6) XB1 der(4) Deleted der(9) der(19) der(6) ZC9 der(4) Deleted der (9) der (19) der (6) PBGD der(4) Deleted der (9) der(19) der(6) THYI der (4) Deleted der(9) der(19) der(6) 8.5
der (4) der (9) der (9) SRPR der(9) XB2 der(4) der (9) ETSl der (9) der (19) 23.2 der(4) 5.8
der (4) CD3G YAC der(4)/ der(9)/ der(9)/ der(11)/ der(6)/ der(11) der (11) der (11) was a clear fluorescence signal both on the rearranged chromosome 11 and on the translocation partner (chromosome 6, 9, or 19) . No signals were observed on any other chromosome. These data enabled us to localize the breakpoint in each translocation to within the 320 kb homologous to these YACs and distal to CD3G. We tested several of the cosmid probes (4.13, ZC9, PBGD, ZB6) to determine whether they were contained within the YACs; no positive hybridization was found.
The YAC identified with the IFNA gene was hybridized to cells from one of the patients who had a t (9;11) ; the YAC probe remained on the der(9). This confirmed our results of in situ hybridizations in which we used a radiolabeled IFNA probe (20) . This YAC also contained the IFNBI gene located on 9p, which suggests that the breakpoint in 9p is distal to the entire IFN gene cluster.
DISCUSSION
The use of the CD3G YACs has alLowed us to identify the translocation breakpoint in band 11q23 in four different chromosomal translocations. The 4;11 translocation is seen primarily in ALL, whereas the 6;11 and 9;11 translocations are generally restricted to AML, most often of the monoblastic or myelomonocytic subtypes. The t(11;19) has been observed with about equal frequency in both ALL and AML. We recognize that the identification of the breakpoint within this yeast clone containing 320 kb of human DNA does not necessarily imply that the breakpoint is precisely the same in all four translocations. The situation could be analogous to the 9;22 translocation in chronic myeloid leukemia and in Ph1-positive ALL, in which the same gene, BCR, is involved but the breakpoints are separated by at least 50-100 kb (21 (22) and Tunnacliffe et al. (23) have shown that the three genes-y, 8 , and E-lie within a 50-kb segment. The 'y and 8 genes are separated by 1 kb, whereas 8 and E are 22-26 kb apart. In an earlier study, Gold et al. (24) showed that CD3D and CD3E remained on the der(11) chromosome in somatic cell hybrids derived from the RS4;11 cell line. These results are consistent with our findings with the CD3D cosmid, which hybridized to the der(11) in each of the four translocations that we examined. Our results establish that the order of these genes is cen-CD3E-CD3D-CD3G-tel. (27) and showed that NCAM, CD3D, and CD3E remained on the der(11) chromosome, whereas THY] and ETSI were translocated to the der(4) chromosome. Yunis et al. (28) obtained the same results using a t(4;11) hybrid cell line derived from another patient. These data are concordant with the results we obtained with cosmid probes. In addition, our data as well as those of Yunis et al. (28) indicate that the PBGD and SRPR genes are distal to the breakpoint.
By using fluorescence in situ hybridization of probes to normal metaphase cells, Lichter et al. (14) prepared a highresolution map of chromosome 11. Our analysis of cells with translocations involving 11q23 using the same probes has allowed us to refine the map of this band. The 4.13, 9.4, and (6;11) ; the cosmid has been translocated to the der(6) chromosome. (B) Cosmid ZB6 remains on the der(11) in a cell with the t(4;11). The location of the CD3G YACs on the normal 11 at band q23 and on both derivative translocation chromosomes is illustrated in C-F. The YACs are split as a result of the translocations; therefore, the signal is less intense on the rearranged chromosomes. (C) In this cell with a t(9;11), the normal 9 is in the center. The der(11) is on the left and the der(9) is at the top of the cell. (D) In this cell with a t(6;11), the normal 6 is on the perimeter at the bottom. The der(11) is on the right and the der(6) is near the top right of the cell. (E) In this t(4;11) cell, the normal 4 is on the perimeter near the bottom. The der(11) is on the left and the der(4) is on the perimeter near the top of the cell. (F) In this t(11;19) cell, the normal 19 is on the perimeter at the bottom. The der (19) is in the center and the der(11) chromosome is at the top in this cell. ZA7 cosmids were previously mapped together within the region containing 1.16. The results of our hybridizations indicate that 4.13 and 1.16 are proximal, whereas 9.4 and ZA7 are distal to the 11q23 breakpoints. Similarly, the CD3D, PBGD, XB1, and XH5 probes were grouped together (14) ; however, our results show that CD3D is proximal to PBGD, XB1, and XH5, which are distal to the translocation breakpoints. Moreover, the deletion of seven cosmid probes from the der(9) chromosome in one patient with the t(9;11) suggests that they are nearer to the breakpoint than are SRPR and other cosmids not included in the deletion.
We have previously studied the 9;11 translocation by using probes for the interferon gene cluster on 9p and for the ETSJ gene (20) . Our data appeared to show that the a-interferon (IFNA) gene cluster remained on 9p, whereas the IFNBI gene moved to 11q. ETSJ was translocated to 9p. Our present evidence (M.O.D. and J.D.R., unpublished data) indicates that the IFNA and IFNBI genes are on the same 1400-kb Not I fragment. This fragment is not rearranged in leukemia cells containing the 9;11 translocation, suggesting that the translocation does not split this gene cluster. Our results with IFN YAC probes support this conclusion and show that the breakpoint in 9p22 is distal to the entire IFN gene cluster.
The use of biotin-labeled probes that are detected by fluorescence microscopy has a number of advantages compared with the use of radiolabeled probes. The probes are quite specific when appropriate blocking strategies are used to prevent nonspecific hybridization from the repetitive sequences in the probes. The signal is visualized as discrete fluorescent dots; thus, the location of the probe can be determined quite precisely. In most cells, both chromosome homologs (and frequently both chromatids) are labeled; therefore, the signal on the normal chromosome provides an internal control. Chromosome-specific centromere probes unequivocally mark a pair of chromosomes, which can then be scored for the presence or absence of the signal from a particular probe.
The use of YAC clones for screening of recurring translocations and identification of those that are split by the translocation breakpoints provides an entirely new strategy for identifying DNA clones that contain the relevant breakpoints. With this technique, the detailed molecular analysis is focused on a particular DNA fragment that contains the segment of interest. It is clear that this approach will be equally useful in defining the limits of chromosome deletions. In our study, both the normal chromosome 11 and the rearranged 11 or the translocation partner were labeled (except for the one patient who had a deletion encompassing seven cosmid probes). Small chromosome deletions, undetectable cytogenetically, have been observed in association with reciprocal translocations-e.g., BCR deletions in chronic myeloid leukemia-and they may occur as a result of the translocation (29) . Larger chromosome deletions have also been observed as recurring abnormalities in human tumors as well as in genetic diseases; in the case of tumors, they are important mechanisms leading to hemizygosity and loss of function of tumor suppressor genes. The use of YAC clones or other large genomic clones for defining the genetic composition of chromosome deletions should expedite the identification of the involved genes (30) .
